These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 18563559)

  • 1. Binding of paroxetine to the serotonin transporter in membranes from different cells, subcellular fractions and species.
    Cupello A; Albano C; Gatta E; Scarrone S; Villa E; Zona G
    Neurochem Res; 2009 Feb; 34(2):255-9. PubMed ID: 18563559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo effect of antidepressants on [3H]paroxetine binding to serotonin transporters in rat brain.
    Nadgir SM; Malviya M
    Neurochem Res; 2008 Nov; 33(11):2250-6. PubMed ID: 18437564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is the platelet serotonin transporter different in venous vs. arterial blood?
    Villa E; Albano C; Cappelli A; Favale E; Fugassa E; Gerdoni E; Scarrone S; Cupello A
    Neurochem Res; 2005 Nov; 30(11):1365-7. PubMed ID: 16341932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Computation-guided analysis of paroxetine binding to hSERT reveals functionally important structural elements and dynamics.
    Abramyan AM; Slack RD; Meena S; Davis BA; Newman AH; Singh SK; Shi L
    Neuropharmacology; 2019 Dec; 161():107411. PubMed ID: 30391505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dimethyltryptamine and other hallucinogenic tryptamines exhibit substrate behavior at the serotonin uptake transporter and the vesicle monoamine transporter.
    Cozzi NV; Gopalakrishnan A; Anderson LL; Feih JT; Shulgin AT; Daley PF; Ruoho AE
    J Neural Transm (Vienna); 2009 Dec; 116(12):1591-9. PubMed ID: 19756361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allosteric modulation of the effect of escitalopram, paroxetine and fluoxetine: in-vitro and in-vivo studies.
    Mansari ME; Wiborg O; Mnie-Filali O; Benturquia N; Sánchez C; Haddjeri N
    Int J Neuropsychopharmacol; 2007 Feb; 10(1):31-40. PubMed ID: 16448580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemical and structural investigation of the paroxetine-human serotonin transporter complex.
    Coleman JA; Navratna V; Antermite D; Yang D; Bull JA; Gouaux E
    Elife; 2020 Jul; 9():. PubMed ID: 32618269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methodologic pitfalls in measurement of 5-hydroxytriptamine uptake transporters in human platelets by [3H]-paroxetine binding assay.
    Jurado N; Torner C; Heinze G; López G; Mendoza-Sotelo J; Lazo-Langner A; Moreno J
    Arch Med Res; 2003; 34(5):422-7. PubMed ID: 14602510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Seasonal variations in the binding of [3H]paroxetine to the platelet serotonin transporter sites in African-American cocaine-dependent patients and healthy volunteers.
    Patkar AA; Berrettini WH; Lundy A; Murray HW; Hill KP; Vergare MJ; Weinstein SP
    Hum Psychopharmacol; 2003 Mar; 18(2):103-11. PubMed ID: 12590403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Binding of S-citalopram and paroxetine discriminates between species.
    Elfving B; Wiborg O
    Synapse; 2005 Mar; 55(4):280-2. PubMed ID: 15668984
    [No Abstract]   [Full Text] [Related]  

  • 11. Associating in vitro target binding and in vivo CNS occupancy of serotonin reuptake inhibitors in rats: the role of free drug concentrations.
    Bundgaard C; Sveigaard C; Brennum LT; Stensbøl TB
    Xenobiotica; 2012 Mar; 42(3):256-65. PubMed ID: 22017605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serotonin transporter gene promoter polymorphisms modify the association between paroxetine serotonin transporter occupancy and clinical response in major depressive disorder.
    Ruhé HG; Ooteman W; Booij J; Michel MC; Moeton M; Baas F; Schene AH
    Pharmacogenet Genomics; 2009 Jan; 19(1):67-76. PubMed ID: 18987562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paroxetine binding to the rat norepinephrine transporter in vivo.
    Owens MJ; Knight DL; Nemeroff CB
    Biol Psychiatry; 2000 May; 47(9):842-5. PubMed ID: 10812044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Novel Bromine-Containing Paroxetine Analogue Provides Mechanistic Clues for Binding Ambiguity at the Central Primary Binding Site of the Serotonin Transporter.
    Slack RD; Abramyan AM; Tang H; Meena S; Davis BA; Bonifazi A; Giancola JB; Deschamps JR; Naing S; Yano H; Singh SK; Newman AH; Shi L
    ACS Chem Neurosci; 2019 Sep; 10(9):3946-3952. PubMed ID: 31424193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aging, estradiol and time of day differentially affect serotonin transporter binding in the central nervous system of female rats.
    Krajnak K; Rosewell KL; Duncan MJ; Wise PM
    Brain Res; 2003 Nov; 990(1-2):87-94. PubMed ID: 14568333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serotonin2 receptors and the serotonin transporter in the schizophrenic brain.
    Dean B; Hayes W; Opeskin K; Naylor L; Pavey G; Hill C; Keks N; Copolov DL
    Behav Brain Res; 1996; 73(1-2):169-75. PubMed ID: 8788497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serotonin transporter occupancy induced by paroxetine in patients with major depression disorder: a 123I-ADAM SPECT study.
    Catafau AM; Perez V; Plaza P; Pascual JC; Bullich S; Suarez M; Penengo MM; Corripio I; Puigdemont D; Danus M; Perich J; Alvarez E
    Psychopharmacology (Berl); 2006 Dec; 189(2):145-53. PubMed ID: 17033844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serotonin transporter and MAO-B levels in monoamine nuclei of the human brainstem are normal in major depression.
    Klimek V; Roberson G; Stockmeier CA; Ordway GA
    J Psychiatr Res; 2003; 37(5):387-97. PubMed ID: 12849931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mouse strain differences in SSRI sensitivity correlate with serotonin transporter binding and function.
    Jin ZL; Chen XF; Ran YH; Li XR; Xiong J; Zheng YY; Gao NN; Li YF
    Sci Rep; 2017 Aug; 7(1):8631. PubMed ID: 28819255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in the serotonin transporter in the hippocampus of subjects with schizophrenia identified using [3H]paroxetine.
    Naylor L; Dean B; Opeskin K; Pavey G; Hill C; Keks N; Copolov D
    J Neural Transm (Vienna); 1996; 103(6):749-57. PubMed ID: 8836936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.